肽能系统作为抗肿瘤靶点：对抗癌症的正确方向？
Peptidergic Systems as Antitumor Targets: A Right Direction to Fight Cancer?
作者信息
Rodríguez Francisco D, Coveñas Rafael
机构信息
Department of Biochemistry and Molecular Biology, Faculty of Chemical Sciences, University of Salamanca, 37007 Salamanca, Spain.
Group GIR-BMD (Bases Moleculares del Desarrollo), University of Salamanca, 37007 Salamanca, Spain.
出版信息
Cancers (Basel). 2023 Oct 13;15(20):4975. doi: 10.3390/cancers15204975.
Abstract
Undoubtedly, much progress has been made in treating cancer over the past few years, but unfortunately, 28 [...].
摘要
毫无疑问，在过去几年里，癌症治疗已经取得了很大进展，但不幸的是，28 [...].
相似文献
1
Peptidergic Systems as Antitumor Targets: A Right Direction to Fight Cancer?肽能系统作为抗肿瘤靶点：对抗癌症的正确方向？
Cancers (Basel). 2023 Oct 13;15(20):4975. doi: 10.3390/cancers15204975.
2
[Laparoscopy in traumatic abdominal emergencies].[创伤性腹部急症中的腹腔镜检查]
Chir Ital. 2006 Jul-Aug;58(4):485-91.
3
Peptidergic innervation in pars distalis of the human anterior pituitary.人垂体前叶远侧部的肽能神经支配。
Brain Res. 2004 May 15;1008(1):61-8. doi: 10.1016/j.brainres.2003.12.055.
4
Non-peptidergic primary afferents are presynaptic to neurokinin-1 receptor immunoreactive lamina I projection neurons in rat spinal cord.非肽能初级传入纤维在大鼠脊髓中神经激肽-1 受体免疫反应性Ⅰ层投射神经元的突触前。
Mol Pain. 2012 Sep 10;8:64. doi: 10.1186/1744-8069-8-64.
5
Design of Nanoparticles in Cancer Therapy Based on Tumor Microenvironment Properties.基于肿瘤微环境特性的癌症治疗纳米颗粒设计
Pharmaceutics. 2022 Dec 3;14(12):2708. doi: 10.3390/pharmaceutics14122708.
6
[The brain peptidergic signaling systems in diabetes mellitus].[糖尿病中的脑肽能信号系统]
Tsitologiia. 2012;54(10):733-41.
7
Tumor antigen-unbiased variable epitope library contains mimotopes with antitumor effect in a mouse model of breast cancer.肿瘤抗原非偏向性可变表位文库包含在乳腺癌小鼠模型中具有抗肿瘤作用的模拟表位。
Mol Immunol. 2023 May;157:91-100. doi: 10.1016/j.molimm.2023.03.019. Epub 2023 Mar 30.
8
The ventral peptidergic system of the adult ascidian Ciona robusta (Ciona intestinalis Type A) insights from a transgenic animal model.成年海鞘（Ciona intestinalis Type A）腹神经肽系统的研究：来自转基因动物模型的启示。
Sci Rep. 2020 Feb 5;10(1):1892. doi: 10.1038/s41598-020-58884-w.
9
Peptidergic and muscarinic excitation at amphibian sympathetic synapses.两栖类交感神经突触处的肽能和毒蕈碱能兴奋
J Physiol. 1983 Aug;341:257-78. doi: 10.1113/jphysiol.1983.sp014805.
10
Neuropeptide signaling near and far: how localized and timed is the action of neuropeptides in brain circuits?远近不同的神经肽信号传导：神经肽在脑回路中的作用在空间和时间上是如何定位的？
Invert Neurosci. 2009 Nov;9(2):57-75. doi: 10.1007/s10158-009-0090-1. Epub 2009 Sep 16.
引用本文的文献
1
Cancer and neurotransmitter receptors.癌症与神经递质受体
Chin Med J (Engl). 2025 Jul 5;138(13):1540-1558. doi: 10.1097/CM9.0000000000003656. Epub 2025 May 30.
本文引用的文献
1
Neuropeptide Y Peptide Family and Cancer: Antitumor Therapeutic Strategies.神经肽 Y 肽家族与癌症：抗肿瘤治疗策略。
Int J Mol Sci. 2023 Jun 9;24(12):9962. doi: 10.3390/ijms24129962.
2
Cell-Penetrating Peptides (CPPs) as Therapeutic and Diagnostic Agents for Cancer.细胞穿透肽（CPPs）作为癌症的治疗和诊断剂
Cancers (Basel). 2022 Nov 11;14(22):5546. doi: 10.3390/cancers14225546.
3
How Far beyond Diabetes Can the Benefits of Glucagon-like Peptide-1 Receptor Agonists Go? A Review of the Evidence on Their Effects on Hepatocellular Carcinoma.胰高血糖素样肽-1受体激动剂的益处能超越糖尿病多远？关于其对肝细胞癌影响的证据综述
Cancers (Basel). 2022 Sep 24;14(19):4651. doi: 10.3390/cancers14194651.
4
Combination Therapy of Chemotherapy or Radiotherapy and the Neurokinin-1 Receptor Antagonist Aprepitant: A New Antitumor Strategy?化疗或放疗与神经激肽-1受体拮抗剂阿瑞匹坦的联合治疗：一种新的抗肿瘤策略？
Curr Med Chem. 2023;30(16):1798-1812. doi: 10.2174/0929867329666220811152602.
5
The Galaninergic System: A Target for Cancer Treatment.甘丙肽能系统：癌症治疗的一个靶点。
Cancers (Basel). 2022 Aug 1;14(15):3755. doi: 10.3390/cancers14153755.
6
Involvement of the Substance P/Neurokinin-1 Receptor System in Cancer.P物质/神经激肽-1受体系统在癌症中的作用
Cancers (Basel). 2022 Jul 21;14(14):3539. doi: 10.3390/cancers14143539.
7
Neuropeptides in Cancer: Friend and Foe?神经肽在癌症中的作用：朋友还是敌人？
Adv Biol (Weinh). 2022 Sep;6(9):e2200111. doi: 10.1002/adbi.202200111. Epub 2022 Jul 1.
8
Hypoxia-inducible factors: cancer progression and clinical translation.缺氧诱导因子：癌症进展与临床转化。
J Clin Invest. 2022 Jun 1;132(11). doi: 10.1172/JCI159839.
9
Why Use Aprepitant Only as a Cough Suppressant in Lung Cancer When at Higher Doses it Could Also Exert an Antitumor Action?当阿瑞匹坦大剂量使用时还可发挥抗肿瘤作用，为何在肺癌治疗中仅将其用作止咳药？
Arch Bronconeumol. 2022 Oct;58(10):727-728. doi: 10.1016/j.arbres.2022.05.004. Epub 2022 May 13.
10
The Neurokinin-1 Receptor Is Essential for the Viability of Human Glioma Cells: A Possible Target for Treating Glioblastoma.神经激肽-1受体对人胶质瘤细胞的存活至关重要：一种治疗胶质母细胞瘤的潜在靶点。
Biomed Res Int. 2022 Apr 4;2022:6291504. doi: 10.1155/2022/6291504. eCollection 2022.
Zotero 插件